已核实 DOI PubMed 相关产品: 10

LIFUS-driven engineered bacteria reprogram immunosuppressive niches via mechano-NOTCH signaling

Journal 2026 · IF 14 · 发表于 2026 年 3 月 9 日
作者: Lizhou Lin,Xiao Li,Wenyun Guo,Jirong Xie,Xiaolong Li,Xin Guan,Chongke Zhao,HaoHao Yin,Huixiong Xu
阅读全文 在 PubMed 查看

摘要

Solid tumors impose coupled stromal and immunologic barriers that limit T cell infiltration and function. Here, we engineer Salmonella VNP 20009 to express gas vesicles (GVs), creating an intratumoral cavitation source that converts low-intensity focused ultrasound (LIFUS) into localized mechanical forces. LIFUS-activated GVs remodel the tumor microenvironment by reducing cancer-associated fibroblast (CAF) abundance, decompressing the matrix, and selectively disrupting CAF-CD8 + T cell communication via a mechanosensitive Notch1-Jagged1 axis. Single-cell RNA sequencing reveals a redistribution of CD8 + T cell states, characterized by enrichment of cytotoxic effector populations and attenuation of NOTCH signaling in memory-associated cells. These biomechanical changes enhance intratumoral CD8 + T cell infiltration and restore effector cytokine production. Leveraging this mechanism, we develop a mechano-priming approach for adoptive T cell therapies. Pre-conditioning with LIFUS-driven GVs improves CD8 + T cell cytotoxicity, strengthens tumor cell adhesion, reduces exhaustion signatures, and achieves durable tumor control and extended survival in orthotopic and metastatic models.

本研究中使用的阿拉丁产品

10 款产品在本文中被引用